AGR2 and cancer: Therefore, the interpretation of our results requires caution, and it seems that AGR2 downregulation may act more strongly as a downstream effector of TGF-β in the focal adhesion pathway leading to an enhanced cascade of signaling events favoring cancer progression and dissemination.